EPI 1:10,000 Flashcards
Epi 1:10,000
Class
Sympathomimetic
Epi 1:10,000
Mechanism of Action
Direct-acting alpha- and beta-agonist. Alpha: vasoconstriction. Beta-1: positive inotropic, chronotropic, and dromotropic effects. Beta-2: bronchial smooth muscle relaxation and dilation of skeletal vasculature.
Epi 1:10,000
Indications
Cardiac arrest (V-fib/pulseless V-tach, Asystole, PEA), anaphylaxis. Should not be used for patients who do not require extensive resuscitative efforts.
Epi 1:10,000
Contraindications
Hypothermia, pulmonary edema, myocardial ischemia, hypovolemic shock
Epi 1:10,000
Relative Contraindications
Underlying cardiovascular disease/angina, hypertension, pregnancy, patients over 40 years of age, hyperthyroidism
Epi 1:10,000
Adverse Reactions
Hypertension, tachycardia, arrhythmias, pulmonary edema, anxiety, restlessness, psychomotor agitation, nausea, headache, and angina.
Epi 1:10,000
Drug Interactions
Potentiates other sympathomimetics, deactivated by alkaline solutions, (i.e. Sodium bicarbonate), monoamine oxidase inhibitors (MAOIs) may potentiate effects, beta-blockers may blunt effects.
Epi 1:10,000
Cardiac Arrest
IV/ IO Dose
1 mg (10 mL of 1:10,000 solution) every 3 – 5 minutes during resuscitation. Follow each dose with 20 mL flush and evaluate arm for 10 – 20 seconds after dose. Higher doses (up to 0.2 mg/kg) may be administered for specific conditions (beta-blocker and calcium channel- blocker overdose).
Epi 1:10,000
ET Dose for Cardiac Arrest
2 – 2.5 mg diluted in 10 mL normal saline
Epi 1:10,000
Continuous Infusion
Add 1 mg (1 mL of 1:1,000 solution) to 500 mL of NS or D5W. Initial infusion rate of 1 mcg/min titrated to effect (typical dose 2 – 10 mcg/min).
Epi 1:10,000
Profound Bradycardia or Hypotension
2 – 10 mcg/min; titrate to patient response.
Epi 1:10,000
Pediatric
Cardiac Arrest IV/ IO dose
0.01 mg/kg (0.01 mL/kg) of 1:10,000 solution every 3 – 5 minutes during arrest.
Epi 1:10,000
Onset
immediate with peak effects in minutes.
Epi 1:10,000
Duration
several minutes
Epi 1:10,000
Special Considerations
May cause syncope in asthmatic children. May increase myocardial oxygen demand.